The need for safe remote monitoring during the COVID-19 epidemic:

As the need for remote health monitoring intensifies during the COVID-19 epidemic, Sensyne Health are developing and deploying products that enable patient groups to record their health information and be safely managed at home, clinicians to deliver continued contact and care, and healthcare organisations such as the NHS to reduce pressure on their resources.

Data generated from these products contributes to medical research aimed at predicting, diagnosing, treating and preventing a variety of conditions including COVID-19 infection.

The clinical AI company improving patient care and accelerating medical research

In collaboration with life sciences companies and our NHS partners, we use AI to detect hidden patterns in anonymised patient data, accelerating the development of new medicines.

Alongside this, we develop clinically validated digital health products which help clinicians deliver better patient care while curating vital data to support the next generation of medical research.

A new approach that benefits patients, the NHS and life sciences

Our unique docking station business model between the NHS and the life sciences industry creates value from the analysis of anonymised patient data in an ethical way and provides a return to the NHS.

For life sciences

Transforming R&D in life sciences

By applying our Clinical AI methods to anonymised NHS patient data, we help life sciences companies develop new treatments faster and at lower cost to address unmet patient needs.

For clinicians & patients

Delivering better patient care

We develop clinically validated digital health products that create clinician and patient benefit while gathering curated data.

Our NHS partnerships

Our Strategic Research Agreements (SRAs) with NHS Trusts allow us access to the unique, longitudinal anonymised patient datasets that only the NHS can provide.

Read more

Our business aims to have a double bottom line, providing an attractive return to our shareholders and making a positive social impact; improving health and generating wealth that we share with our NHS Trust partners.

Our social impact

Latest article

Latest news

Press release
Sensyne Health makes GDm-Health™ remote monitoring system for the management of diabetes in pregnancy available free-of-charge across NHS in response to COVID-19 pandemic.
2020-03-27
Press release
GDm-Health™ remote monitoring system made available free-of-charge during COVID-19 pandemic
2020-03-27
Press release
Sensyne Health awarded a prestigious HSJ Partnership Award in providing a digital health solution for diabetes during pregnancy that has helped prevent pre-term births, C-sections and the need for pharmacological treatment. Diabetes during pregnancy affects thousands of mothers-to-be each year and can lead to serious complications in pregnancy.
2020-02-28
Press release
Sensyne Health recognised for its impact in helping treat diabetes in pregnancy
2020-02-28
View all News